Source: http://www.thefederalregister.com/d.p/2006-11-27-06-9391
Timestamp: 2013-05-21 07:20:53
Document Index: 44949116

Matched Legal Cases: ['art 7114', 'art 3944', 'art 6726', 'art 140', 'art 5250', 'art 1739', 'art 30206', 'art 514', 'art 9740', 'art 180']

Uniform Formulary Beneficiary Advisory Panel, Daily Rules, Proposed Rules, and Notices of the Federal Government
14 CFR Part 7114 CFR Part 3944 CFR Part 6726 CFR Part 140 CFR Part 5250 CFR Part 1739 CFR Part 30206 CFR Part 514 CFR Part 9740 CFR Part 180	Federal Register: November 27, 2006 (Volume 71, Number 227)
DOCID: FR Doc 06-9391
SUBJECT CATEGORY: Meeting of the Uniform Formulary Beneficiary Advisory Panel DATES: Wednesday, December 20, 2006, from 8 a.m. to 4 p.m.
DOCUMENT SUMMARY: This notice announces a meeting of the Uniform Formulary Beneficiary Advisory Panel. The panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The meeting will be open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Notice of this meeting is required under the Federal Advisory Committee Act.
SUMMARY: Uniform Formulary Beneficiary Advisory Panel, SUPPLEMENTAL INFORMATION
The Uniform Formulary Beneficiary Advisory Panel will only review and comment on the development of the Uniform Formulary as reflected in the recommendations of the DOD Pharmacy and Therapeutics (P&T) Committee coming out of that body's meeting in November 2006. The P&T Committee information and subject matter concerning drug classes reviewed for that meeting are available at http://pec.ha.osd.mil. Any private citizen is permitted to file a written statement with the advisory panel. Statements must be submitted electronically to baprequests@tma.osd.mil no later than December 13, 2006. Any private citizen is permitted to speak at the Beneficiary Advisory Panel meeting, time permitting. One hour will be reserved for public comments, and speaking times will be assigned only to the first twelve citizens to sign up at the meeting, on a firstcome, first
served basis. The amount of time allocated to a speaker will not exceed five minutes. Dated: November 20, 2006. L.M. Bynum, Alternate OSD Federal Register Liaison Officer, DoD. [FR Doc. 069391 Filed 112406; 8:45 am]
Major Travis Watson, TRICARE Management Activity, Pharmaceutical Operations Directorate, Beneficiary Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone 7036812890, fax 7036811940 or email at baprequests@tma.osd.mil.